1887

Abstract

The human antibody response to polyomavirus capsid proteins is not well characterized. Recombinant BK virus (BKV), JC virus (JCV) and simian virus 40 (SV40) virus-like particles (VLP) were produced in a baculovirus system, and mouse monoclonal antibodies (mAbs) to these proteins were generated using standard methods. Nine of 12 BKV mAbs showed neutralizing activity. The non-neutralizing antibodies also bound BKV pseudocapsids in an ELISA binding assay. Most antibodies recognized conformational species-specific epitopes, but several exceptions were found: (i) BKV mAb BK-F11 cross-reacted with a linear buried epitope common to both JCV and SV40 pseudocapsids, (ii) two of six JCV antibodies (JC-6.7 and JC-7.9) and two of 13 SV40 antibodies (VP1-H2 and VP1-I2) recognized linear buried epitopes common to all three viruses and (iii) SV40 antibody VP1-E5 recognized a linear surface epitope on JCV pseudocapsids.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.008391-0
2009-03-01
2020-10-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/3/634.html?itemId=/content/journal/jgv/10.1099/vir.0.008391-0&mimeType=html&fmt=ahah

References

  1. Atwood W. J. 2001; A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy. J Neurovirol 7:307–310 [CrossRef]
    [Google Scholar]
  2. Bohl D. L., Ryschkewitsch C., Major E. O., Storch G. A., Brennan D. C. 2005; BK virus antibody titers markedly increase with viremia. Am J Transplant 5:Suppl.273
    [Google Scholar]
  3. Carter J. J., Madeleine M. M., Wipf G. C., Garcea R. L., Pipkin P. A., Minor P. D., Galloway D. A. 2003; Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 95:1522–1530 [CrossRef]
    [Google Scholar]
  4. Christensen N. D., Dillner J., Eklund C., Carter J. J., Wipf G. C., Reed C. A., Cladel N. M., Galloway D. A. 1996a; Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 223:174–184 [CrossRef]
    [Google Scholar]
  5. Christensen N. D., Reed C. A., Cladel N. M., Hall K., Leiserowitz G. S. 1996b; Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology 224:477–486 [CrossRef]
    [Google Scholar]
  6. Culp T. D., Christensen N. D. 2003; Quantitative RT-PCR assay for HPV infection in cultured cells. J Virol Methods 111:135–144 [CrossRef]
    [Google Scholar]
  7. de Sanjose S., Shah K. V., Domingo-Domenech E., Engels E. A., Fernandez de Sevilla A., Alvaro T., Garcia-Villanueva M., Romagosa V., Gonzalez-Barca E., Viscidi R. P. 2003; Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 104:522–524 [CrossRef]
    [Google Scholar]
  8. Drachenberg C. B., Beskow C. O., Cangro C. B., Bourquin P. M., Simsir A., Fink J., Weir M. R., Klassen D. K., Bartlett S. T., Papadimitriou J. C. 1999; Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol 30:970–977 [CrossRef]
    [Google Scholar]
  9. Drachenberg R. C., Drachenberg C. B., Papadimitriou J. C., Ramos E., Fink J. C., Wali R., Weir M. R., Cangro C. B., Klassen D. K. other authors 2001; Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant 1:373–381 [CrossRef]
    [Google Scholar]
  10. Drachenberg C. B., Papadimitriou J. C., Wali R., Cubitt C. L., Ramos E. 2003; BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am J Transplant 3:1383–1392 [CrossRef]
    [Google Scholar]
  11. Engels E. A., Viscidi R. P., Galloway D. A., Carter J. J., Cerhan J. R., Davis S., Cozen W., Severson R. K., de Sanjose S. other authors 2004; Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst 96:1368–1374 [CrossRef]
    [Google Scholar]
  12. Flaegstad T., Traavik T., Christie K. E., Joergensen J. 1986; Neutralization test for BK virus: plaque reduction detected by immunoperoxidase staining. J Med Virol 19:287–296 [CrossRef]
    [Google Scholar]
  13. Fleury M. J., Touze A., de Sanjose S., Bosch F. X., Klaustermeiyer J., Coursaget P. 2008; Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions. Clin Vaccine Immunol 15:172–175 [CrossRef]
    [Google Scholar]
  14. Hamilton R. S., Gravell M., Major E. O. 2000; Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J Clin Microbiol 38:105–109
    [Google Scholar]
  15. Hariharan S., Cohen E. P., Vasudev B., Orentas R., Viscidi R. P., Kakela J., DuChateau B. 2005; BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transplant 5:2719–2724 [CrossRef]
    [Google Scholar]
  16. Hirsch H. H., Mohaupt M., Klimkait T. 2001; Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 184:1494–1495 [CrossRef]
    [Google Scholar]
  17. Jafar S., Rodriguez-Barradas M., Graham D. Y., Butel J. S. 1998; Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol 54:276–284 [CrossRef]
    [Google Scholar]
  18. Knowles W. A., Pipkin P., Andrews N., Vyse A., Minor P., Brown D. W., Miller E. 2003; Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71:115–123 [CrossRef]
    [Google Scholar]
  19. Krymskaya L., Sharma M. C., Martinez J., Haq W., Huang E. C., Limaye A. P., Diamond D. J., Lacey S. F. 2005; Cross reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 79:11170–11178 [CrossRef]
    [Google Scholar]
  20. Mylonakis E., Goes N., Rubin R. H., Cosimi A. B., Colvin R. B., Fishman J. A. 2001; BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation 72:1587–1592 [CrossRef]
    [Google Scholar]
  21. Nickeleit V., Hirsch H. H., Binet I. F., Gudat F., Prince O., Dalquen P., Thiel G., Mihatsch M. J. 1999; Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 10:1080–1089
    [Google Scholar]
  22. Ramos E., Drachenberg C. B., Papadimitriou J. C., Hamze O., Fink J. C., Klassen D. K., Drachenberg R. C., Wiland A., Wali R. other authors 2002; Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 13:2145–2151 [CrossRef]
    [Google Scholar]
  23. Randhawa P. S., Demetris A. J. 2000; Nephropathy due to polyomavirus type BK. N Engl J Med 342:1361–1363 [CrossRef]
    [Google Scholar]
  24. Randhawa P. S., Finkelstein S., Scantlebury V., Shapiro R., Vivas C., Jordan M., Pickin M. M., Demetris A. J. 1999; Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 67:103–109 [CrossRef]
    [Google Scholar]
  25. Randhawa P. S., Vats A., Shapiro R., Weck K., Scantlebury V. 2002a; BK virus: discovery, epidemiology, and biology. Graft 5:Suppl.S19–S27 [CrossRef]
    [Google Scholar]
  26. Randhawa P. S., Vats A., Zygmunt D., Swalsky P. A., Scantlebury V., Shapiro R., Finkelstein S. 2002b; Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 74:485–488 [CrossRef]
    [Google Scholar]
  27. Randhawa P. S., Gupta G., Vats A., Shapiro R., Viscidi R. P. 2006; Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol 13:1057–1063 [CrossRef]
    [Google Scholar]
  28. Rizk R. Z., Christensen N. D., Michael K. M., Müller M., Sehr P., Waterboer T., Pawlita M. 2008; Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. J Gen Virol 89:117–129 [CrossRef]
    [Google Scholar]
  29. Rosen S., Harmon W., Krensky A. M., Edelson P. J., Padgett B. L., Grinnell B. W., Rubino M. J., Walker D. L. 1983; Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med 308:1192–1196 [CrossRef]
    [Google Scholar]
  30. Shah K. V., Ozer H. L., Ghazey H. N., Kelly T. J. 1977; Common structural antigen of papovaviruses of the simian virus 40-polyoma subgroup. J Virol 21:179–186
    [Google Scholar]
  31. Tevethia S. S., Schell T. D. 2001; The immune response to SV40, JCV, and BKV. In Human polyomaviruses: molecular and clinical perspectives . pp 585–610Edited by Khalili K., Stoner. New York: Wiley-Liss;
  32. Thönes N., Herreiner A., Schädlich L., Piuko K., Müller M. 2008; A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response. J Virol 82:5472–5485 [CrossRef]
    [Google Scholar]
  33. Vallbracht A., Löhler J., Gossmann J., Glück T., Petersen D., Gerth H. J., Gencic M., Dörries K. 1993; Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 143:29–39
    [Google Scholar]
  34. Viscidi R. P., Clayman B. 2006; Serological cross reactivity between polyomavirus capsids. In Polyomaviruses and human diseases pp 73–84Edited by Ahsan N. G. L. New York: Springer;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.008391-0
Loading
/content/journal/jgv/10.1099/vir.0.008391-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error